Pulse Biosciences, Inc.

This study is testing a new device that uses electrical pulses to shrink benign (non-cancerous) thyroid nodules without surgery. About 100 adults with symptomatic thyroid nodules will receive the treatment and be followed for up to 12 months to see how much the nodule shrinks and…

This study is testing a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this procedure. The goal is to…

This study tests a new device that uses electrical pulses to treat atrial fibrillation (an irregular heartbeat) while patients are already having heart surgery for other reasons. About 135 adults aged 18 to 85 with a history of atrial fibrillation will take part. The goal is to s…

This study tests a new device called the CellFX nsPFA catheter, which uses very short electrical pulses to fix faulty heart tissue in people with paroxysmal atrial fibrillation (a type of irregular heartbeat). The goal is to see if it is safe and works well. About 215 adults aged…

This early study tests a new device that uses short electrical pulses to treat atrial fibrillation (an irregular heartbeat) during heart surgery. About 30 adults aged 18-85 with a history of atrial fibrillation will receive the treatment. The goal is to see if the device safely c…